• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Eaton Vance Tax Advantaged Dividend Inc

Eaton Vance Tax Advantaged Dividend Inc

  1. All
  2. 3rd Party
  1. Evotec Achieves Clinical Development Milestone as Part of Its Multi-Target Alliance with Bayer in Endometriosis

    Evotec Achieves Clinical Development Milestone as Part of Its Multi-Target Alliance with Bayer in Endometriosis

  2. Some CEFs Are Getting a One-Time Boost to NAV

    The potential for rising rates casts ARPS in a new light, and falling commodity prices continue to pressure MLP closed-end funds.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.